Willy Ye

Willy Ye

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Heart Rhythm
Verified
Journal Article
Closed access
RLRuo-Gu Li
Ruo-Gu Li
YXYing-Jia Xu
Ying-Jia Xu
WYWilly Ye
Willy Ye
YLYan-Jie Li
Yan-Jie Li
HCHonghong Chen
Honghong Chen
DBDonglin Bai
Donglin Bai

1 October 2017 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
WYWilly Ye
Willy Ye
BYBenny Yue
Benny Yue
HAHiroshi Aoyama
Hiroshi Aoyama
NKNicholas K. Kim
Nicholas K. Kim
JCJohn A. Cameron
John A. Cameron
DBDonglin Bai
Donglin Bai

21 February 2023 in Biology
Verified
Journal Article
Open access
PDF file
YLYan-Jie Li
Yan-Jie Li
JWJuan Wang
Juan Wang
WYWilly Ye
Willy Ye
XLXing-Yuan Liu
Xing-Yuan Liu
LLLi Li
Li Li
RHRi-Tai Huang
Ri-Tai Huang
As the most prevalent type of birth malformation, congenital heart disease (CHD) gives rise to substantial mortality and morbidity as well as a socioeconomic burden. Although aggregating investigations highlight the genetic basis for CHD, the genetic determinants underpinning CHD remain largely obscure. In this research, a Chinese family suffering from autosomal dominant CHD (atrial septal defect) and arrhythmias was enrolled. A genome-wide genotyping with microsatellite markers followed by linkage assay as well as sequencing analysis was conducted. The functional effects of the discovered genetic mutation were characterized by dual patch-clamp electrophysiological recordings in N2A cells and propidium iodide uptake assays in HeLa cells. As a result, a novel genetic locus for CHD and arrhythmias was located on chromosome 17q21.31-q21.33, a 4.82-cM (5.12 Mb) region between two markers of D17S1861 and D17S1795. Sequencing assays of the genes at the mapped locus unveiled a novel heterozygous mutation in the GJC1 gene coding for connexin 45 (Cx45), NM_005497.4:c.550A>G;p.R184G, which was in co-segregation with the disease in the whole family and was not observed in 516 unrelated healthy individuals or gnomAD. Electrophysiological analyses revealed that the mutation significantly diminished the coupling conductance in homomeric cell pairs (R184G/R184G) and in cell pairs expressing either R184G/Cx45 or R184G/Cx43. Propidium iodide uptake experiments demonstrated that the Cx45 R184G mutation did not increase the Cx45 hemichannel function. This investigation locates a new genetic locus linked to CHD and arrhythmias on chromosome 17q21.31-q21.33 and indicates GJC1 as a novel gene predisposing to CHD and arrhythmias, implying clinical implications for prognostic risk assessment and personalized management of patients affected with CHD and arrhythmias.

1 January 2016 in Journal of Molecular and Cellular Cardiology
Verified
Journal Article
Closed access
AJArjewan Jassim
Arjewan Jassim
HAHiroshi Aoyama
Hiroshi Aoyama
WYWilly Ye
Willy Ye
HCHonghong Chen
Honghong Chen
DBDonglin Bai
Donglin Bai

14 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YSYiguo Sun
Yiguo Sun
MHMatthew D. Hills
Matthew D. Hills
WYWilly Ye
Willy Ye
XTXiaoling Tong
Xiaoling Tong
DBDonglin Bai
Donglin Bai
Mutations in GJA5 encoding the gap junction protein connexin40 (Cx40) have been linked to lone atrial fibrillation. Some of these mutants result in impaired gap junction function due to either abnormal connexin localization or impaired gap junction channels, which may play a role in promoting atrial fibrillation. However, the effects of the atrial fibrillation-linked Cx40 mutants on hemichannel function have not been studied. Here we investigated two atrial fibrillation-linked germline Cx40 mutants, V85I and L221I. These two mutants formed putative gap junction plaques at cell-cell interfaces, with similar gap junction coupling conductance as that of wild-type Cx40. Connexin deficient HeLa cells expressing either one of these two mutants displayed prominent propidium iodide-uptake distinct from cells expressing wild-type Cx40 or other atrial fibrillation-linked Cx40 mutants, I75F, L229M, and Q49X. Propidium iodide-uptake was sensitive to [Ca2+]o and the hemichannel blockers, carbenoxolone, flufenamic acid and mefloquine, but was not affected by the pannexin 1 channel blocking agent, probenecid, indicating that uptake is most likely mediated via connexin hemichannels. A gain-of-hemichannel function in these two atrial fibrillation-linked Cx40 mutants may provide a novel mechanism underlying the etiology of atrial fibrillation.